Cardarine
Also known as: GW501516, GW1516, GW-501516, Endurobol, GSK-516
Classification
Unknown
Regulatory Status
not-established
Sources
2
Review
n/a
Overview
Cardarine (GW501516) is a peroxisome proliferator-activated receptor delta (PPAR-delta) agonist historically explored for metabolic and dyslipidemia indications. Development stopped after multi-organ carcinogenicity signals in animals. It is not a SARM despite frequent co-marketing.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
Interactions & cautions
Drug interactions
other unapproved metabolic modulators or SARM stacks — No clinical interaction map; stacking unapproved agents adds unquantified risk. (high)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw